Palavras-chave
Como Citar
Resumo
Heart failure (HF) and chronic kidney disease (CKD) are frequently interrelated conditions that significantly affect patients' quality of life and survival. Both conditions share common risk factors, such as diabetes mellitus and hypertension, and can exacerbate each other. HF can lead to deterioration in renal function due to reduced renal blood flow and activation of neurohormonal mechanisms. Conversely, CKD can worsen HF by causing volume overload and disrupting electrolyte balance. Managing these conditions requires an integrated approach that considers the complex interactions between the cardiovascular and renal systems. Objective: To analyze the therapeutic and surgical options available for treating heart failure in patients with chronic kidney disease and evaluate their impact on patients' prognosis. Methodology: The study followed the PRISMA checklist and involved a systematic search of PubMed, Scielo, and Web of Science databases. Keywords included "heart failure," "chronic kidney disease," "therapeutic options," "surgical options," and "prognosis." Inclusion criteria were articles published in the last 10 years, studies addressing both HF and CKD, and research providing data on therapeutic or surgical interventions. Studies focusing solely on one condition, articles outside the review's scope, and non-peer-reviewed research were excluded. Results: The results indicated that an integrated treatment approach, including risk factor management, specific pharmacotherapy, and surgical interventions, can significantly improve patient prognosis. Therapeutic options, such as ACE inhibitors and angiotensin receptor blockers, have shown benefits in reducing symptoms and disease progression. Surgical interventions, such as coronary revascularization and kidney transplantation, were also associated with improvements in clinical outcomes. Conclusion: Emphasized that a combined and multidisciplinary approach is essential to optimize treatment and quality of life for these patients, highlighting the importance of personalized and integrated strategies for therapeutic success.
Referências
Stone GW, Farkouh ME, Lala A, Tinuoye E, Dressler O, Moreno PR, Palacios IF, Goodman SG, Esper RB, Abizaid A, Varade D, Betancur JF, Ricalde A, Payro G, Castellano JM, Hung IFN, Nadkarni GN, Giustino G, Godoy LC, Feinman J, Camaj A, Bienstock SW, Furtado RHM, Granada C, Bustamante J, Peyra C, Contreras J, Owen R, Bhatt DL, Pocock SJ, Fuster V; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19. J Am Coll Cardiol. 2023 May 9;81(18):1747-1762. doi: 10.1016/j.jacc.2023.02.041.
Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, A Figtree G, Ge J, G Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation. 2024 May 21;149(21):1627-1638. doi: 10.1161/CIRCULATIONAHA.124.069217.
Bove M, Cicero AF, Veronesi M, Borghi C. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia. Vasc Health Risk Manag. 2017 Feb 8;13:23-28. doi: 10.2147/VHRM.S115080.
Matsumoto S, Henderson AD, Shen L, Yang M, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Solomon SD, Pitt B, Zannad F, Jhund PS, McMurray JJV. Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function. J Am Coll Cardiol. 2024 Jun 18;83(24):2426-2436. doi: 10.1016/j.jacc.2024.03.426.
Janečková J, Bachleda P, Utíkal P. Reduction of arteriovenous access blood flow in kidney transplant patients. Rozhl Chir. 2022 Spring;101(5):227-231. English. doi: 10.33699/PIS.2022.101.5.227-231.
Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, Denti P, Latib A, Kiaii B, Bagur R, Ferrari E, Moccetti M, Biasco L, Blanke P, Ben-Gal Y, Banai S. Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement. Circ Cardiovasc Interv. 2018 Oct;11(10):e006412. doi: 10.1161/CIRCINTERVENTIONS.118.006412.
El-Chami MF, Clementy N, Garweg C, Omar R, Duray GZ, Gornick CC, Leyva F, Sagi V, Piccini JP, Soejima K, Stromberg K, Roberts PR. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. JACC Clin Electrophysiol. 2019 Feb;5(2):162-170. doi: 10.1016/j.jacep.2018.12.008.
Malik A, Longi F, Naeem A, Clemence JJ, Makkinejad A, Norton E, Wu X, Patel HJ, Deeb GM, Yang B. Outcomes in Patients With Chronic Renal Failure on Hemodialysis After Aortic Valve or Root Replacement. Semin Thorac Cardiovasc Surg. 2022 Autumn;34(3):880-888. doi: 10.1053/j.semtcvs.2021.05.019.
Rizwan M, Aridi HD, Dang T, Alshwaily W, Nejim B, Malas MB. Long-Term Outcomes of Carotid Endarterectomy and Carotid Artery Stenting When Performed by a Single Vascular Surgeon. Vasc Endovascular Surg. 2019 Apr;53(3):216-223. doi: 10.1177/1538574418823379.
She K, Zhang X, Yin J, Cheng G, Chen X. [Long-term results of chest wall arteriovenous graft for establishing hemodialysis access]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Feb 15;33(2):227-231. Chinese. doi: 10.7507/1002-1892.201802003.
Xing CF, Pan X, Wang C, Ma L, Wang XL, Li YJ, He B. [Long-term outcome of transcatheter repair of paravalvular leak post surgical mitral valve replacement]. Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jul 24;51(7):742-749. Chinese. doi: 10.3760/cma.j.cn112148-20230604-00327.
Ramanan B, Jeon-Slaughter H, Chen X, Modrall JG, Tsai S. Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg. 2019 Oct;70(4):1217-1224. doi: 10.1016/j.jvs.2018.12.054.
Patel SM, Kang YM, Im K, Neuen BL, Anker SD, Bhatt DL, Butler J, Cherney DZI, Claggett BL, Fletcher RA, Herrington WG, Inzucchi SE, Jardine MJ, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Solomon SD, Staplin N, Vaduganathan M, Wanner C, Wheeler DC, Zannad F, Zhao Y, Heerspink HJL, Sabatine MS, Wiviott SD. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation. 2024 Jun 4;149(23):1789-1801. doi: 10.1161/CIRCULATIONAHA.124.069568.
DeKeyser GJ, Wilson JM, Kellam PJ, Spencer C, Haller JM, Rothberg DL, Wagner ER, Higgins TF, Marchand LS. Young Intertrochanteric Femur Fractures Are Associated With Fewer Complications than Young Femoral Neck Fractures. J Orthop Trauma. 2021 Jul 1;35(7):356-360. doi: 10.1097/BOT.0000000000002005.
Lum SH, Albert MH, Gilbert P, Sirait T, Algeri M, Muratori R, Fournier B, Laberko A, Karakukcu M, Unal E, Ayas M, Yadav SP, Fisgin T, Elfeky R, Fernandes J, Faraci M, Cole T, Schulz A, Meisel R, Zecca M, Ifversen M, Biffi A, Diana JS, Vallée T, Giardino S, Ersoy GZ, Moshous D, Gennery AR, Balashov D, Bonfim C, Locatelli F, Lankester A, Neven B, Slatter M. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity. Blood. 2024 Aug 1;144(5):565-580. doi: 10.1182/blood.2024024038.
Hernandez AF, Udell JA, Jones WS, Anker SD, Petrie MC, Harrington J, Mattheus M, Seide S, Zwiener I, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chen Y, Chopra VK, A Figtree G, Ge J, G Goodman S, Gotcheva N, Goto S, Gasior T, Jamal W, Januzzi JL, Jeong MH, Lopatin Y, Lopes RD, Merkely B, Parikh PB, Parkhomenko A, Ponikowski P, Rossello X, Schou M, Simic D, Steg PG, Szachniewicz J, van der Meer P, Vinereanu D, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Butler J. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial. Circulation. 2024 May 21;149(21):1627-1638. doi: 10.1161/CIRCULATIONAHA.124.069217.
Bove M, Cicero AF, Veronesi M, Borghi C. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia. Vasc Health Risk Manag. 2017 Feb 8;13:23-28. doi: 10.2147/VHRM.S115080.
Matsumoto S, Henderson AD, Shen L, Yang M, Swedberg K, Vaduganathan M, van Veldhuisen DJ, Solomon SD, Pitt B, Zannad F, Jhund PS, McMurray JJV. Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Impaired Renal Function. J Am Coll Cardiol. 2024 Jun 18;83(24):2426-2436. doi: 10.1016/j.jacc.2024.03.426.
Janečková J, Bachleda P, Utíkal P. Reduction of arteriovenous access blood flow in kidney transplant patients. Rozhl Chir. 2022 Spring;101(5):227-231. English. doi: 10.33699/PIS.2022.101.5.227-231.
Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, Denti P, Latib A, Kiaii B, Bagur R, Ferrari E, Moccetti M, Biasco L, Blanke P, Ben-Gal Y, Banai S. Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement. Circ Cardiovasc Interv. 2018 Oct;11(10):e006412. doi: 10.1161/CIRCINTERVENTIONS.118.006412.
El-Chami MF, Clementy N, Garweg C, Omar R, Duray GZ, Gornick CC, Leyva F, Sagi V, Piccini JP, Soejima K, Stromberg K, Roberts PR. Leadless Pacemaker Implantation in Hemodialysis Patients: Experience With the Micra Transcatheter Pacemaker. JACC Clin Electrophysiol. 2019 Feb;5(2):162-170. doi: 10.1016/j.jacep.2018.12.008.
Malik A, Longi F, Naeem A, Clemence JJ, Makkinejad A, Norton E, Wu X, Patel HJ, Deeb GM, Yang B. Outcomes in Patients With Chronic Renal Failure on Hemodialysis After Aortic Valve or Root Replacement. Semin Thorac Cardiovasc Surg. 2022 Autumn;34(3):880-888. doi: 10.1053/j.semtcvs.2021.05.019.
Rizwan M, Aridi HD, Dang T, Alshwaily W, Nejim B, Malas MB. Long-Term Outcomes of Carotid Endarterectomy and Carotid Artery Stenting When Performed by a Single Vascular Surgeon. Vasc Endovascular Surg. 2019 Apr;53(3):216-223. doi: 10.1177/1538574418823379.
She K, Zhang X, Yin J, Cheng G, Chen X. [Long-term results of chest wall arteriovenous graft for establishing hemodialysis access]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019 Feb 15;33(2):227-231. Chinese. doi: 10.7507/1002-1892.201802003.
Xing CF, Pan X, Wang C, Ma L, Wang XL, Li YJ, He B. [Long-term outcome of transcatheter repair of paravalvular leak post surgical mitral valve replacement]. Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jul 24;51(7):742-749. Chinese. doi: 10.3760/cma.j.cn112148-20230604-00327.
Ramanan B, Jeon-Slaughter H, Chen X, Modrall JG, Tsai S. Comparison of open and endovascular procedures in patients with critical limb ischemia on dialysis. J Vasc Surg. 2019 Oct;70(4):1217-1224. doi: 10.1016/j.jvs.2018.12.054.
Patel SM, Kang YM, Im K, Neuen BL, Anker SD, Bhatt DL, Butler J, Cherney DZI, Claggett BL, Fletcher RA, Herrington WG, Inzucchi SE, Jardine MJ, Mahaffey KW, McGuire DK, McMurray JJV, Neal B, Packer M, Perkovic V, Solomon SD, Staplin N, Vaduganathan M, Wanner C, Wheeler DC, Zannad F, Zhao Y, Heerspink HJL, Sabatine MS, Wiviott SD. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis. Circulation. 2024 Jun 4;149(23):1789-1801. doi: 10.1161/CIRCULATIONAHA.124.069568.
DeKeyser GJ, Wilson JM, Kellam PJ, Spencer C, Haller JM, Rothberg DL, Wagner ER, Higgins TF, Marchand LS. Young Intertrochanteric Femur Fractures Are Associated With Fewer Complications than Young Femoral Neck Fractures. J Orthop Trauma. 2021 Jul 1;35(7):356-360. doi: 10.1097/BOT.0000000000002005.
Lum SH, Albert MH, Gilbert P, Sirait T, Algeri M, Muratori R, Fournier B, Laberko A, Karakukcu M, Unal E, Ayas M, Yadav SP, Fisgin T, Elfeky R, Fernandes J, Faraci M, Cole T, Schulz A, Meisel R, Zecca M, Ifversen M, Biffi A, Diana JS, Vallée T, Giardino S, Ersoy GZ, Moshous D, Gennery AR, Balashov D, Bonfim C, Locatelli F, Lankester A, Neven B, Slatter M. Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity. Blood. 2024 Aug 1;144(5):565-580. doi: 10.1182/blood.2024024038.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Thelma da Costa, Euripedes da Costa Machado, Layla Azevedo Alencastro Cupertino de Barros, Lara Lacerda Amaro, Rayane Alves Cruz, Matheus do Carmo Rodrigues, Stefanny Machado Correa, Gabriel Nojosa Oliveira, Pedro Felipe Rezende Martins, Melissa Meireles Coelho de Oliveira, Pollyanna de Cárita Apolinário, Vítor Emídio Câncio